FDA Inspection
BEO Pharma IncBEO Pharma Inc – FDA Inspection, Nov 4, 2024
Record Details
This FDA Inspection record concerns BEO Pharma Inc, with an inspection on November 4, 2024, issued by the Florida District Office, covering human drugs.
View Company Profile
ID · e258df89-955c-4c64-bc54-2dbe54610e44
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1253295
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.84(d)(1)Identity Testing of Each Component
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BEO Pharma Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2026 | Not classified | Florida District Office | Drug Quality Assurance |
Other documents for BEO Pharma Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.